We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESV
2951
DELISTED
Ensco Rowan plc
ESV
$331K ﹤0.01%
9,793
-5,104
-34% -$146K
FNDF icon
2952
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
$329K ﹤0.01%
10,995
-11,368
-51% -$338K
LGF.A
2953
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$326K ﹤0.01%
13,363
+5,036
+60% +$119K
LPT
2954
DELISTED
Liberty Property Trust
LPT
$326K ﹤0.01%
7,715
-561
-7% -$24.4K
FTLS icon
2955
First Trust Long/Short Equity ETF
FTLS
$2.49B
$325K ﹤0.01%
8,029
+379
+5% +$15.2K
WRI
2956
DELISTED
Weingarten Realty Investors
WRI
$325K ﹤0.01%
10,908
-8,486
-44% -$258K
VUSE icon
2957
Vident US Equity Strategy ETF
VUSE
$691M
$324K ﹤0.01%
+9,379
New +$325K
MCI
2958
Barings Corporate Investors
MCI
$341M
$323K ﹤0.01%
21,097
+4
+0% +$61
MIN
2959
Aberdeen Intermediate Income Fund
MIN
$278M
$323K ﹤0.01%
85,864
-12,557
-13% -$47.7K
TVRD
2960
Tvardi Therapeutics
TVRD
$22M
$323K ﹤0.01%
374
+11
+3% +$7.94K
KGC icon
2961
Kinross Gold
KGC
$32.5B
$322K ﹤0.01%
119,128
+2,550
+2% +$8.26K
DCP
2962
DELISTED
DCP Midstream, LP
DCP
$322K ﹤0.01%
8,126
+171
+2% +$7.19K
SEDG icon
2963
SolarEdge
SEDG
$1.98B
$321K ﹤0.01%
8,522
-23,549
-73% -$1.13M
HUBG icon
2964
HUB Group
HUBG
$2.9B
$319K ﹤0.01%
13,970
+4,260
+44% +$106K
MOTI icon
2965
VanEck Morningstar International Moat ETF
MOTI
$77.1M
$319K ﹤0.01%
9,659
HTO
2966
H2O America
HTO
$2.56B
$319K ﹤0.01%
5,217
+555
+12% +$34.4K
TSI
2967
TCW Strategic Income Fund
TSI
$213M
$319K ﹤0.01%
56,940
-11,700
-17% -$64.9K
MYGN icon
2968
Myriad Genetics
MYGN
$311M
$318K ﹤0.01%
+6,919
New +$308K
IQDF icon
2969
FlexShares International Quality Dividend Index Fund
IQDF
$1.17B
$317K ﹤0.01%
13,174
-13,289
-50% -$323K
ABDC
2970
DELISTED
Alcentra Capital Corp
ABDC
$317K ﹤0.01%
52,965
-33,799
-39% -$211K
TNET icon
2971
TriNet
TNET
$3.09B
$316K ﹤0.01%
5,602
+1,199
+27% +$67.4K
HMSY
2972
DELISTED
HMS Holdings Corp.
HMSY
$316K ﹤0.01%
9,642
-1,484
-13% -$42.9K
REET icon
2973
iShares Global REIT ETF
REET
$5.04B
$315K ﹤0.01%
12,510
+1,185
+10% +$30.7K
SEB icon
2974
Seaboard Corp
SEB
$4.06B
$315K ﹤0.01%
85
Z icon
2975
Zillow
Z
$7.59B
$315K ﹤0.01%
7,110
-5,090
-42% -$265K

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.